Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | HUM | Humana Common | 590 | Dec 31, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HUM | Restricted Stock Units | Award | $10.2K | +22 | +4.29% | $465.85 | 535 | Dec 31, 2021 | Humana Common | 22 | Direct | F2 | |
transaction | HUM | Restricted Stock Units | Award | $3.26K | +7 | +233.33% | $465.85 | 10 | Dec 31, 2021 | Humana Common | 7 | Direct | F3 | |
transaction | HUM | Restricted Stock Units | Award | $0 | +412 | $0.00 | 412 | Jan 3, 2022 | Humana Common | 412 | Direct | F4 | ||
holding | HUM | Restricted Stock Units | 856 | Dec 31, 2021 | Humana Common | 856 | Direct | F1 |
Id | Content |
---|---|
F1 | Annual Director's fee payable in stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). |
F2 | Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). |
F3 | Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). |
F4 | Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. |